MWV Presents on Bioequivalence Standards for Drug Delivery Components at Pharmapack NA

As the generics industry continues to grow - approaching $100 billion in the U.S.

- so too does the need for bioequivalence studies that prove generic versions are identical to original formulations. What some might not know is that the rigorous standards and criteria for performing bioequivalence studies also extend to drug delivery components.

Rabih Karam, North American Sales Manager, Healthcare, for MeadWestvaco Corporation, a global leader in packaging and packaging solutions, will present MWV nasal devices equivalence data in his talk “Equivalence in Nasal Pump Systems for Generic Products in the US Market” at the inaugural Pharmapack NA pharmaceutical packaging conference in Philadelphia, Wednesday, May 23 at 11:20am.

Please let us know if you would be interested in talking with Rabih, who will also discuss how rigorous bioequivalence studies are an essential part of registration dossiers for the formulation and manufacture of generic medicines.

More information is available here.
Companies in this article
More in Home